Announcements
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports First Quarter 2024 Financial Results
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
- Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
- Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
- Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
- Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
- Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
- Pulmonx to Participate at Upcoming Investor Conferences
- Pulmonx Reports Record Third Quarter 2023 Financial Results
More ▼
Key statistics
On Thursday, Pulmonx Corp (4NI:DUS) closed at 5.75, 8.49% above its 52-week low of 5.30, set on Jun 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.75 |
---|---|
High | 5.80 |
Low | 5.75 |
Bid | 5.75 |
Offer | 5.90 |
Previous close | 5.75 |
Average volume | 0.00 |
---|---|
Shares outstanding | 38.82m |
Free float | 36.77m |
P/E (TTM) | -- |
Market cap | 244.54m USD |
EPS (TTM) | -1.54 USD |
Data delayed at least 15 minutes, as of Jul 04 2024 18:31 BST.
More ▼